Susan Hasty, Publisher
Table of Contents . . . September 5th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Vaccine Weekly | Other Publications
Influenza - Cost Burden Of ILI In Elderly Highlights Importance Of Vaccination
Therapy (HAV) - HAV Vaccination More Effective Before Decompensation In Hepatic Disease
Allergies - Adjuvant Speeds Relief For Pollen Sufferers
Immune Response - Combination Hepatitis Vaccine Remains Effective In Long-Term Follow-Up
Safety - Gelatin Sensitivity Explains Some Delayed Reactions to JE Vaccine
Travel Medicine - Second Influenza Vaccination Makes No Difference In Elderly Travelers
AIDS Therapies - Phase I Clinical Trial Of Monoclonal Antibody Initiated
Cardiopulmonary Bypass - Anti-Factor D Antibody Reduces Systemic Inflammation
Chickenpox - About Three Million Children Head To School Unvaccinated
Cholera - Vietnam Campaign Achieves Full Coverage For 83% Of Targeted Population
Drug Development - New Class Of Antibody Drug Candidate Discovered
Economics - Two-Dose Hepatitis B Vaccination Expected To Reduce Costs In Long Run
HIV Vaccines - Scientists Determine Structure Of Antibody That Neutralizes HIV
Human Papillomavirus - Virus-Like Particles Induce Antibody, Cytokine Responses In Chimps
Influenza - DNA Plasmid Protects Mice From Lethal Challenge
Influenza - Vaccine Achieves Protection When Delivered With MF59 Adjuvant
Lyme Disease - IL-6 Enhances Anti-B. burgdorferi Antibody Production
Melanoma - Ganglioside Vaccine Induces Tumor Protection In B16 Mouse Model
Meningitis - Conjugate, Polysaccharide Vaccines Induce Mucosal Immunity
Shigella - Intranasal Vaccine Demonstrates Safety, Immunogenicity
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.